Duaa H. Al-Rawi, MD, PhD
Gynecologic Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Request an Appointment
About Me
- Instructor
I am a gynecologic medical oncologist who specializes in the diagnosis and treatment of ovarian cancer, endometrial cancer, and cervical cancer.
I became interested in the field of oncology while I was pursuing my PhD at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology. During my doctoral training, I studied the biochemical functions of the genes that lead to higher risk of breast and ovarian cancer, including the BRCA1 gene. My interactions with physician-scientists and their patients inspired me to care for people diagnosed with cancer.
This led me to transition to medical school at Stanford University where I pursued an internal medicine residency. I enjoy caring for patients and I connected most strongly with the women who came to me for care, which led me to focus on gynecologic medical oncology. I pursued my medical fellowship at Memorial Sloan Kettering Cancer Center (MSK), one of the few centers where medical oncologists treat people with gynecologic cancers. I was excited by the opportunity to train at MSK and feel deeply privileged to care for people with gynecologic cancers.
A cancer diagnosis can emotionally and physically challenging and I aim to create a warm environment for my patients. Beyond providing excellent clinical care, I welcome patients from diverse backgrounds and aim to honor their values. This extends from respecting cultural and religious values, using preferred pronouns, and being open during challenging discussions. I aim to support both my team and my patients to create a culture of mutual respect.
My research is focused on modeling and detecting early invasive ovarian cancer by studying serous tubal intraepithelial carcinoma (STIC) lesions, which are benign lesions inside the fallopian tube. People with STIC lesions may be at higher risk of developing cancer and I use single cell sequencing and spatial transcriptomics to research how these lesions can lead to ovarian cancer.
I am passionate about improving treatment and detection of ovarian cancer through a better understanding of how ovarian cancer originates or develops. It is critical that we provide monitoring for people who are found to have STIC lesions while we work to identify their levels of risk for cancer and determine the best surveillance and treatment guidelines for them.
Outside of clinical care and research, I enjoy spending time with my family, going to farmers markets, traveling, exploring New York City, and cooking.
A gynecologic (GY-neh-kuh-LAH-jik) medical oncologist is a cancer doctor who specializes in gynecologic cancers. This includes cervical, fallopian tube, ovarian, uterine (endometrial), vaginal, and vulvar cancers.
My Specialties
- Gynecologic Cancers
- Ovarian Cancer
- Endometrial Cancer
- Cervical Cancer
Residencies
- Internal Medicine, Stanford University Medical Center
Awards and Honors
- Ovarian Cancer Research Alliance, Mentored Investigator Grant (2023-24)
- Conquer Cancer Foundation, Young Investigator Award (2024)
- Mary Kay Ash Foundation Pilot Research Grant (2022-24)
Fellowships
- Medical Oncology, Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine, Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Al-Rawi sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
1. Agustinus AS, Al-Rawi D, Dameracharla B, Raviram R, Jones BSCL, Stransky S, Scipioni L, Luebeck J, Di Bona M, Norkunaite D, Myers RM, Duran M, Choi S, Weigelt B, Yomtoubian S, McPherson A, Toufektchan E, Keuper K, Mischel PS, Mittal V, Shah SP, Maciejowski J, Storchova Z, Gratton E, Ly P, Landau D, Bakhoum MF, Koche RP, Sidoli S, Bafna V, David Y, Bakhoum SF. Epigenetic dysregulation from chromosomal transit in micronuclei. Nature. 2023 Jul;619(7968):176-183. PubMed Central PMCID: PMC10322720.
2. Al-Rawi DH, Rusk N, Friedman CF. The Search for Genomic Biomarkers of Response to Immunotherapy in Ovarian Cancer. Clin Cancer Res. 2023 May 1;29(9):1645-1647. PubMed Central PMCID: PMC10159911.
3. Al-Rawi DH, Bakhoum SF. Chromosomal instability as a source of genomic plasticity. Curr Opin Genet Dev. 2022 Jun;74:101913. PubMed Central PMCID: PMC9156567.
4. Navitski A, Al-Rawi DH, Liu Y, Rubinstein MM, Friedman CF, Rampal RK, Mandelker DL, Cadoo K, O’Cearbhaill RE. Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer. Gynecol Oncol Rep. 2021 Nov;38:100873. PubMed Central PMCID: PMC8651772.
5. Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell. 2005 Dec 29;123(7):1213-26. PubMed PMID: 16377563.
Visit PubMed for a full listing of Dr. Al-Rawi’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.